Millipore Sigma Vibrant Logo

376817 Hexokinase II Inhibitor II, 3-BP - CAS 1113-59-3 - Calbiochem

The Hexokinase II Inhibitor II, 3-BP, also referenced under CAS 1113-59-3, controls the biological activity of Hexokinase II. This small molecule/inhibitor is primarily used for Cell Structure applications.

MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: 3-BrPA, Bromopyruvate, Bromopyruvatic Acid, 3-Bromo-2-oxopropionic acid

View Products on Sigmaaldrich.com
376817
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
1113-59-3C₃H₃BrO₃

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
376817-100MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 100 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewA cell-permeable pyruvic acid derivative that acts as an inhibitor against hexokinase II-mediated glycolysis and effectively suppress tumor survival both in cultures in vitro and in mice and rats in vivo.
      Catalogue Number376817
      Brand Family Calbiochem®
      Synonyms3-BrPA, Bromopyruvate, Bromopyruvatic Acid, 3-Bromo-2-oxopropionic acid
      References
      ReferencesBujis, M., et al. 2009. Invest. New Drugs 27, 120.
      Chen, Z., et al. 2009. Biochim. Biophys. Acta. 1787, 553.
      Hulleman, E., et al. 2009. Blood. 113, 2014;
      Mathupala, S.P., et al. 2009. Semin. Cancer Biol. 19, 17.
      Pereira da Silva, A.P., et al. 2009. Biochem. J. 417, 717.
      Yun, J., et al. 2009. Science. 325, 1555.
      Zhang, X., et al. 2009. Anticancer Res. 29, 1443.
      Kim, J.S., et al. 2008. J. Bioenerg. Biomembr. 40, 607.
      Product Information
      CAS number1113-59-3
      EC number214-206-5
      FormWhite crystalline solid
      Hill FormulaC₃H₃BrO₃
      Chemical formulaC₃H₃BrO₃
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥97% by Titration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSUZ0840000
      Safety Information
      R PhraseR: 34

      Causes burns.
      S PhraseS: 26-36/37/39-45

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing, gloves and eye/face protection.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Corrosive
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      376817-100MG 04055977212983

      Documentation

      Hexokinase II Inhibitor II, 3-BP - CAS 1113-59-3 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Hexokinase II Inhibitor II, 3-BP - CAS 1113-59-3 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      376817

      Riferimenti bibliografici

      Panoramica delle referenze
      Bujis, M., et al. 2009. Invest. New Drugs 27, 120.
      Chen, Z., et al. 2009. Biochim. Biophys. Acta. 1787, 553.
      Hulleman, E., et al. 2009. Blood. 113, 2014;
      Mathupala, S.P., et al. 2009. Semin. Cancer Biol. 19, 17.
      Pereira da Silva, A.P., et al. 2009. Biochem. J. 417, 717.
      Yun, J., et al. 2009. Science. 325, 1555.
      Zhang, X., et al. 2009. Anticancer Res. 29, 1443.
      Kim, J.S., et al. 2008. J. Bioenerg. Biomembr. 40, 607.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision02-December-2010 RFH
      Synonyms3-BrPA, Bromopyruvate, Bromopyruvatic Acid, 3-Bromo-2-oxopropionic acid
      DescriptionA cell-permeable pyruvic acid derivative that acts as an inhibitor against hexokinase II-mediated glycolysis and effectively suppress tumor survival both in cultures in vitro and in mice and rats in vivo.
      FormWhite crystalline solid
      CAS number1113-59-3
      RTECSUZ0840000
      EC number214-206-5
      Chemical formulaC₃H₃BrO₃
      Structure formulaStructure formula
      Purity≥97% by Titration
      SolubilityDMSO (100 mg/ml) or dH₂O (100 mg/ml)
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Corrosive
      ReferencesBujis, M., et al. 2009. Invest. New Drugs 27, 120.
      Chen, Z., et al. 2009. Biochim. Biophys. Acta. 1787, 553.
      Hulleman, E., et al. 2009. Blood. 113, 2014;
      Mathupala, S.P., et al. 2009. Semin. Cancer Biol. 19, 17.
      Pereira da Silva, A.P., et al. 2009. Biochem. J. 417, 717.
      Yun, J., et al. 2009. Science. 325, 1555.
      Zhang, X., et al. 2009. Anticancer Res. 29, 1443.
      Kim, J.S., et al. 2008. J. Bioenerg. Biomembr. 40, 607.